Alps Group Inc
For the period ended Feb 4, 2026. Filed Feb 5, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Feb 4, 2026 · Filed Feb 5, 2026
Use the contents to explore the available documents and sections.
ALPS$0.33+4.9%Stored close · as of Nov 6, 2026
Contents
EXPLANATORY NOTE
Alps Group Inc (the “Company”) is filing this Report on Form 6-K to report its financial results for the six months ended September 30, 2025 and to discuss its recent corporate developments.
Attached as exhibits to this Report on Form 6-K are:
| (1) | The unaudited pro forma condensed combined financial information and related notes of Alps Group Inc, Alps Life Sciences Inc and Globalink Investment Inc as at September 30 2025 as Exhibit 99.1; |
| (2) | The unaudited financial statements and related notes of Alps Group Inc for the six months ended September 30, 2025 as Exhibit 99.2: |
| (3) | The unaudited consolidated financial statements and related notes of Alps Life Sciences Inc for the six months ended September 30, 2025 as Exhibit 99.3; |
| (4) | The unaudited condensed consolidated financial statements and related notes of Globalink Investment Inc for the nine months ended September 30, 2025 as Exhibit 99.4; |
| (5) | Management’s Discussion and Analysis of Financial Condition and Results of Operations of Alps Life Sciences Inc for the six months ended September 30, 2025 as Exhibit 99.5; |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.